You just read:

Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II Studies

News provided by

Phosplatin Therapeutics LLC

Sep 09, 2017, 09:00 ET